-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/systems/hospital/pressure_ulcer_prevention/pu_training-impguide.docx
October 01, 2017 - Process, Tool 2B
Current Process Analysis, Tool 2C
Assessing Pressure Ulcer Policies, Tool 2D
Assessing Screening … They might include ideas such as universal pressure injury precautions, pressure injury risk screening … policies and practices
Implementation Team Leader
2D: Assessing Pressure Ulcer Policies
2E: Assessing Screening … The protocol includes risk factors and the patient’s body mass index (BMI).
-
www.ahrq.gov/patient-safety/settings/hospital/resource/pressureinjury/guide/apf.html
October 01, 2017 - The protocol includes risk factors and the patient’s body mass index (BMI).
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer
April 11, 2016 - 1.62–2.87)
Cholesterol level (per 1 mmol/L)
0.99 (0.90–1.08)
0.90 (0.77–1.07)
BMI … 1.08–1.19)
Statin
0.67 (0.62–0.71)
PPI
0.84 (0.80–0.88)
BMI
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-bleeding-risks-with-aspirin-use/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - 1.62–2.87)
Cholesterol level (per 1 mmol/L)
0.99 (0.90–1.08)
0.90 (0.77–1.07)
BMI … 1.08–1.19)
Statin
0.67 (0.62–0.71)
PPI
0.84 (0.80–0.88)
BMI
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - Effectiveness Research, AHRQ is interested in innovations
in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … and length
of hospitalizations, and antibiotic use, as well as increasing weight (body mass index [BMI … greater proportion of patients.22 Lumacaftor has demonstrated an ability to increase lung
function and BMI
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
October 01, 2015 - Effectiveness Research, AHRQ is interested in innovations
in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs,
devices, procedures, treatments, screening … and length
of hospitalizations, and antibiotic use, as well as increasing weight (body mass index [BMI … greater proportion of patients.22 Lumacaftor has demonstrated an ability to increase lung
function and BMI
-
effectivehealthcare.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
May 01, 2017 - Analytic framework for osteoarthritis of the knee
Figure notes: BMI = Body Mass Index; KQ = Key Question … OA (sex,
disease subtype,
severity (stage/
pain and functional
status), fitness,
comorbidities,
BMI … DistillerSR™ software was used for
screening, abstraction, reconciliation, and tracking. … suggested by members of the TEP,
peer reviewers, or public reviewers were obtained and
underwent the same screening … Our
literature flow diagram (Figure B) displays our screening
results.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/osteoarthritis-knee-update-executive-170505.pdf
May 01, 2017 - Analytic framework for osteoarthritis of the knee
Figure notes: BMI = Body Mass Index; KQ = Key Question … OA (sex,
disease subtype,
severity (stage/
pain and functional
status), fitness,
comorbidities,
BMI … DistillerSR™ software was used for
screening, abstraction, reconciliation, and tracking. … suggested by members of the TEP,
peer reviewers, or public reviewers were obtained and
underwent the same screening … Our
literature flow diagram (Figure B) displays our screening
results.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
March 10, 2010 - Again report the RR (CI) for each of the BMI groups as it is
not clear what you are trying to communicate
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_disposition-comments.pdf
March 10, 2010 - Again report the RR (CI) for each of the BMI groups as it is
not clear what you are trying to communicate
-
digital.ahrq.gov/sites/default/files/docs/integrating-pros-into-practice-slides-02272024.pdf
February 27, 2024 - Patient Pre-Operative Factors Considered
Age, sex, race
BMI, number of medications
Medicaid status
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Preventive Services Task Force recommends active screening for osteoporosis and
early intervention to … Screening for Osteoporosis: U.S. Preventive
Services Task Force Recommendation
Statement. … Screening
for osteoporosis in the adult U.S. population:
ACPM position statement on preventive
practice … Assessment of
Fracture Risk and Its Application to
Screening for Postmenopausal Osteoporosis. … femur
(femoral neck,
trochanter and Ward’s
triangle); lumbar spine
No NA No NA No NA Balance; BMI
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoporosis-vibration-therapy_technical-brief.pdf
January 01, 2020 - Preventive Services Task Force recommends active screening for osteoporosis and
early intervention to … Screening for Osteoporosis: U.S. Preventive
Services Task Force Recommendation
Statement. … Screening
for osteoporosis in the adult U.S. population:
ACPM position statement on preventive
practice … Assessment of
Fracture Risk and Its Application to
Screening for Postmenopausal Osteoporosis. … femur
(femoral neck,
trochanter and Ward’s
triangle); lumbar spine
No NA No NA No NA Balance; BMI
-
www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer
April 11, 2016 - incidence rates used in the model are derived from U.S. data 49 , 50 and reflect contemporary use of screening … BMI = body mass index; BP = blood pressure; CRC = colorectal cancer; CVD = cardiovascular disease; HDL-C … The model run represented here is based on a birth cohort (starting at age 40 y) with hypertension screening … and treatment, cholesterol screening and treatment, and aspirin for primary and secondary prevention—all
-
www.uspreventiveservicestaskforce.org/uspstf/document/decision-analysis-for-aspirin/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
April 11, 2016 - incidence rates used in the model are derived from U.S. data 49 , 50 and reflect contemporary use of screening … BMI = body mass index; BP = blood pressure; CRC = colorectal cancer; CVD = cardiovascular disease; HDL-C … The model run represented here is based on a birth cohort (starting at age 40 y) with hypertension screening … and treatment, cholesterol screening and treatment, and aspirin for primary and secondary prevention—all
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
October 06, 2006 - 60.0 28
PCI 23 23 69.0 17 Myoprotect I126
CABG 21 21 71.0 43
PCI
138 131 60.3 30 BMI … >30
: 17% Octostent127
CABG
142 136 58.9 28 BMI>30
: 15%
PCI 50 50 53.3 16 BMI>30
: 26% … Poland130 CABG 50 50 54.1 18 BMI>30
: 20%
C-1
Appendix C: Additional Analyses and Evidence … University
D-1
Appendix E: Abstraction Forms
Appendix E: Abstraction Forms
Level One (Screening
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
October 06, 2006 - 60.0 28
PCI 23 23 69.0 17 Myoprotect I126
CABG 21 21 71.0 43
PCI
138 131 60.3 30 BMI … >30
: 17% Octostent127
CABG
142 136 58.9 28 BMI>30
: 15%
PCI 50 50 53.3 16 BMI>30
: 26% … Poland130 CABG 50 50 54.1 18 BMI>30
: 20%
C-1
Appendix C: Additional Analyses and Evidence … University
D-1
Appendix E: Abstraction Forms
Appendix E: Abstraction Forms
Level One (Screening
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - /809 Significant renal impairment;
clinically signficant abnormal results
of physical exam or lab screening … 1.44)
No interactions between
any NSAID and aspirin
use or coronary heart
disease; smoking and
BMI … , et al
2005
NR/NR/550 Significant renal
impairment; clinically
significant
abnormalities on
screening
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
January 01, 2006 - /809 Significant renal impairment;
clinically signficant abnormal results
of physical exam or lab screening … 1.44)
No interactions between
any NSAID and aspirin
use or coronary heart
disease; smoking and
BMI … , et al
2005
NR/NR/550 Significant renal
impairment; clinically
significant
abnormalities on
screening
-
digital.ahrq.gov/sites/default/files/docs/publication/r01hs015169-middleton-final-report-2009.pdf
January 01, 2009 - Hgb A1c levels as continuous variables; quality of documentation: blood pressure, height, weight,
BMI